| Literature DB >> 15381359 |
Caroline Ryschkewitsch1, Peter Jensen, Jean Hou, Gary Fahle, Steven Fischer, Eugene O Major.
Abstract
The presence of the human polyomaviruses JCV and BKV in immunocompromised patients can lead to lethal diseases and conditions including progressive multifocal leukoencephalopathy (PML), interstitial nephritis, hemorrhagic cystitis, and kidney allograft rejection. Typically, detection of JCV and BKV in clinical samples has employed standard PCR amplification for viral nucleotide sequences, with subsequent confirmation for viral genome specificity of PCR products by southern blot hybridization. Here, we directly tested a validated PCR-southern protocol with a TaqMan real-time PCR protocol (Applied Biosystems) to assay clinical samples of urine and cerebrospinal fluid. We found equal specificity and sensitivity with both methods. However, real-time allowed for absolute viral-genome quantitation without the use of radionucleotides and was performed more rapidly, in as little as 24 h. Such advantages are important to consider in the effort to establish international standardization of controls for the detection of JCV and BKV, which would aid in screening confidence and the reliable assessment of anti-viral therapies.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15381359 DOI: 10.1016/j.jviromet.2004.06.021
Source DB: PubMed Journal: J Virol Methods ISSN: 0166-0934 Impact factor: 2.014